England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...

Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA ...